World’ s first trial of lung cancer vaccine launched
20 November 2025 https:// www. ucl. ac. uk / news / 2025 / nov / worlds-first-trial-lung-cancer-vaccine-launched
People at high risk of lung cancer will soon be able to receive the first ever experimental vaccine designed to prevent the disease, in a worldfirst clinical trial led by researchers at UCL and the University of Oxford.
The research team has been awarded up to £ 2.06 million from Cancer Research UK, supported by the CRIS Cancer Foundation, to run a clinical trial of LungVax over the next four years.
This phase I trial will investigate the best dose of LungVax to give to people at high risk of lung cancer, as well as looking for any potential side‐effects from different doses of the vaccine.
The trial is expected to begin in summer 2026, subject to regulatory approvals.